Skip to main content
Equibles
FUNI logo

FUNI · Hypha Labs, Inc.

Track FUNI — free

Use FUNI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FUNI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 0.00 (-4.55%) At close · Oct 19
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As of June 30, 2026, our balance of cash on hand was $5,110, and we had negative working capital of $1,577,350 and an accumulated deficit of $24,996,836 resulting from recurring losses. These factors raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$721,142
Shares
163.90M
Volume · Oct 19 1000 Avg daily vol (3M) 355.26K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.00 Open$0.00 Day$0.00–0.00 52W close$0.00–0.04 Avg vol 30d509K Short int6K · 0.0% float · 1.0d Short vol88% DataJan 2020–Oct 2026 Filing10-Q · Aug 14

Up next

Latest filing: 10-Q
filed Aug 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$2.73M
Trailing 12 months
Net income (TTM)
−$1.91M
Trailing 12 months
Revenue growth YoY
+3.9%
Year over year
Operating margin
-42.6%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+19.7%
Year over year · more shares
Price change (1Y)
-81.4%
Trailing year
Short interest
—
Latest settlement
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Very Weak Sentiment Bullish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 18.4 · elevated Equity put/call 0.55
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −80%
below
Price vs 50-day avg −52%
below
RSI (14) 39
neutral
MACD trend Positive
52-week position 1%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −16%
trailing
6-month return −80%
trailing
YTD return −90%
this year
Relative strength −87%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of float · ▼ -89.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Weak
Revenue growth +132%
Y/Y
Gross margin 56%
contracting
EPS growth −100%
Y/Y
Free cash flow $-412.9K
Balance sheet $2.4M
net debt
Quant / Vol
risk profile
Very High
Volatility 212%
annualized · 1-yr
Max drawdown −90%
past year
ATR 21.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
3 · 2 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−80% Bearish
Price vs 50-day avg
−52% Bearish
RSI (14)
39 Neutral
MACD trend
Positive Bullish
52-week position
1% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of float · ▼ -89.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 1% Range high $0
vs 200-day avg -80% vs 50-day avg -52%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Diagnostics & Research — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
FUNI
Hypha Labs, Inc.
this stock
$721,142 -89.5% +131.9% — 0.0%
TMO
Thermo Fisher Scientific Inc.
 $251.20B +17.2% +14.5% 36.6 1.5%
DHR
Danaher Corp /De/
 $157.77B -2.0% +8.5% 39.8 1.3%
NTRA
Natera, Inc.
 $57.57B +74.4% -2.8% — 4.4%
A
Agilent Technologies, Inc.
 $48.56B +24.9% +6.4% 33.9 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Falling
Shares short
5.9K
Days to cover
1.0d
Change
-49.0K sh
View
Short Volume
Short vol %
88%
As of
Oct 9, 2026
Short Total
View
Fails to Deliver
FTD shares
682
Value
$14
As of
Aug 13, 2026
View
Off-Exchange
Off-exchange %
99.9%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$2.7M
Net income (FY)
$-3.1M
EPS diluted
$-0.02
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 14, 2026
This year
5
View

Performance

5D 20D 120D MTD YTD
FUNI +5.0% -16.0% -79.5% -6.7% -89.5%
SPY -1.5% -0.9% +7.7% +0.5% +12.4%
vs SPY +6.5% -15.1% -87.2% -7.2% -101.9%
Key facts CIK 1502966 CUSIP 253825202 Visit website Investor relations